Article Information
History
- October 20, 2020.
Article Versions
- Version 1 (September 18, 2020 - 14:36).
- Version 2 (September 21, 2020 - 12:15).
- Version 3 (September 25, 2020 - 00:30).
- You are viewing Version 4, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Kaitlyn E. Johnson1,2,3,
- Madison Stoddard3,
- Ryan P. Nolan4,
- Douglas E. White5,
- Natasha S. Hochberg6,7 and
- Arijit Chakravarty3,*
- 1Department of Integrative Biology, The University of Texas at Austin
- 2Department of Biomedical Engineering, The University of Texas at Austin
- 3Fractal Therapeutics, Cambridge, MA
- 4Halozyme Therapeutics, San Diego, CA
- 5Independent Researcher
- 6Department of Epidemiology, Boston University School of Public Health
- 7Department of Medicine, Boston University School of Medicine
- ↵*Corresponding author; email: arijit{at}fractaltx.com